Affinium Pharmaceuticals Obtains $15,000,000 New Round

  • Feed Type
  • Date
    8/29/2011
  • Company Name
    Affinium Pharmaceuticals
  • Mailing Address
    7000 North Mopac Expwy 2nd Floor Austin, TX 78731
  • Company Description
    Affinium is a pharmaceutical company focused on the clinical development of antibacterials. Our lead development program encompasses a potent, orally available, novel antibiotic class for the treatment of antibiotic resistant staphylococcal infections.
  • Website
    http://www.afnm.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This financing will fully fund Affinium’s next two key development goals, the completion of a phase 2 trial for our oral tablet and phase 1 trials of our new IV formulations.
  • M&A Terms
  • Venture Investor
    Forward Ventures
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Genesys Capital

By posting a comment, you agree to our terms and conditions.